Vasoactive Intestinal Peptide (vip) Acetate
Generic Name: vasoactive intestinal peptide (vip) acetate
Dosage form: POWDER. Active ingredients: PEPTIDE B27PD (.5 g/.5g). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.
Overview
Dosage form: POWDER. Active ingredients: PEPTIDE B27PD (.5 g/.5g). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.
Dosage
Available as powder.
Related Medications
Chlorpromazine
chlorpromazine
DESCRIPTION Chlorpromazine hydrochloride, USP, a dimethylamine derivative of phenothiazine, has a chemical formula of 2-chloro-10-[3-(dimethylamino) propyl] phenothiazine monohydrochloride. It is available in tablets for oral administration. It has the following structural formula: Chlorpromazine hydrochloride, USP occurs as white to creamy white, crystalline powder. Each tablet for oral administration contains 10 mg, 25 mg, 50 mg, 100 mg, or 200 mg of chlorpromazine hydrochloride, USP.
Arnica Montana, Calcium Sulfide, Hypericum Perforatum, Lycopodium Clavatum Spore, Thiosinaminum, Mercurius Solubilis, Salicylic Acid, Silicon Dioxide, Allylthiourea
arnica montana, calcium sulfide, hypericum perforatum, lycopodium clavatum spore, thiosinaminum, mercurius solubilis, salicylic acid, silicon dioxide, allylthiourea
Arnica montana HPUS - Buzzing, Chirping Hepar sulph calc HPUS - Noise sensitivity Hypericum perforatum HPUS - Nerve sensitivity Lycopodium clavatum HPUS - Pounding, wax buildup Mercurius sol HPUS - Discomfort Salicylicum acidum HPUS - Ringing, Buzzing Silicea HPUS - Roaring Thiosinaminum HPUS - Ringing (Tinnitus)
Tagraxofusp
tagraxofusp
CD123 Interaction [EPC]
11 DESCRIPTION Tagraxofusp-erzs, a CD123-directed cytotoxin, is a fusion protein comprised of a recombinant human interleukin-3 (IL-3) and truncated diphtheria toxin (DT). Tagraxofusp-erzs has an approximate molecular weight of 57,695 Daltons. Tagraxofusp-erzs is constructed by recombinant DNA technology and produced in Escherichia coli cells.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.